Is This a Blue Zone Thing?

The question lands warmly, with a hint of hope. Costa Rica, plant medicine, a retreat tucked into the rainforest, and somewhere in the first exchange a prospective guest asks whether Nāhua is a "Blue Zone thing." It's offered up the way people would a compliment. The answer disappoints them a little.

No. Nāhua sits on Costa Rica's southern Pacific coast, about 100 miles (160 km) from the Nicoya Peninsula that the Blue Zone label actually points to. But geography is the smaller reason. Even if we were pouring our water up the coast in Nicoya, we would not build a single promise on it. We do not sell longevity. We do not offer the health secrets of the world's oldest people. We do not use the country's reputation as a substitute for evidence. Costa Rica is our home and our setting. It is not our proof.

One principle governs everything we build here: Nāhua does not borrow an attractive story just because the story is convenient. The same claim that can be harmless as folklore becomes reckless when people are making choices about their health. The fact that a claim is charming tells you, well, nothing. Other than it is charming.

When a lovely story turns dangerous

A nice story curdles into a dangerous one when four traits converge. It is attractive, flattering what we already believe, or simply feeling good to hold. It is hard for an outsider to check. It survives correction, shrugging off the inconvenient footnote and carrying on. And it is consequential, the kind of thing people use to make decisions about medicine, money, risk, and trust. A beautiful idea about place or tradition or human flourishing can live happily as inspiration. It becomes a problem the moment someone treats it as a reason to act.

The "danger test" does not require the claim to be flatly false. It also catches the overextended claim, the one that may hold a grain of truth but leads you to believe it's the whole loaf of bread. Some Blue Zone observations may well have merit. None of them is load-bearing for anything we do.

Why the Blue Zone story is so easy to love

The pull is real. The Blue Zone story flatters a set of intuitions many thoughtful people already carry: that traditional life was healthier, that modernity is slowly poisoning us, that community and diet explain what pills cannot, and that a beautiful place might be keeping an old secret. 

Some of that may even be true. Isn't that the danger? Charm is the trait most likely to distract the skeptical part of your brain while it’s still looking for the beach tote.

The evidence has aged less well. Dan Buettner popularized the five Blue Zones (Okinawa, Sardinia, Nicoya, Ikaria, and Loma Linda) through National Geographic and later a Netflix series. Saul Justin Newman, a longevity researcher at Oxford, has argued that many extreme-age records track poverty, missing birth certificates, pension pressure, and sloppy record-keeping far more closely than they track diet or community, and that the moment you introduce reliable birth records, the supercentenarian clusters have a habit of vanishing. His case has now reached a wide audience through Morbid, though parts of the underlying demographic work remain contested and not yet peer reviewed. Blue Zone researchers have pushed back hard. We have no dog in this hunt, so we decline to build on the claim in either direction.

And anyway, the Costa Rican case rewards care over attack. Luis Rosero-Bixby, the demographer most responsible for validating Nicoya's longevity, built his estimates from birth-registration ledger dates rather than from self-reported ages, because age inflates at the very top when people report it themselves. Working from those harder numbers, he confirmed the real thing: Nicoyan men born before 1930 lived extraordinarily long, the oldest cohorts outliving even Japan, the longest-lived nation on earth. Then he did what the longevity industry almost never does. He returned to his own headline finding with a better dataset and, in 2023, reported that the advantage is vanishing. Men born in 1905 carried adult mortality a third below the national rate; those born in 1945 ran higher than average, and the hotspot had contracted to a corridor of roughly 25,000 people. Blue-zone status, he concluded, is probably transient and should be reassessed continuously. 

Newman distrusts the records; Rosero-Bixby trusts them (with caveats) and still watches the miracle fade. They arrive at the same place from opposite directions: the convenient, durable-sounding number cannot be leaned on. That is the discipline, and it is why we treat the Blue Zone question as open and decline to plant a flag on either side.

The longevity market rewards the interesting claim, and the interesting claim is often the least reliable one. Dhruv Khullar, reviewing Newman's book for The New Yorker, reaches the clinical version of the same verdict. The best-supported advice stays stubbornly boring. Move. Sleep. Eat like a reasonable adult. Keep your relationships intact. A retreat that sells you stunning longevity by geographic osmosis is, almost by construction, selling you the version most likely to be wrong.

Aiming the spotlight

Shining an unflattering spotlight on someone else's cherished story is easy. The harder test, the one that separates a trustworthy source from a merely persuasive one, is whether you will turn the same light on the stories you love.

So we do. One of the filters we use to decide what belongs in Nāhua's program is the Concordance Principle. When part of the case for including a practice rests on humans having used that practice deliberately across many cultures and long stretches of time, the Concordance Principle asks how good that anthropological evidence is, and lets only the strong cases count toward what we run here. (It also looks for neurobiological plausibility, but that's a different essay for another time.)

Discarding the weak evidence is part of deciding what earns a place in our own program. The Tassili rock-art reading, the Norse berserker thesis, and the Vedic Soma identification are exactly the citations a retreat like ours, one that leans on plant medicine, is expected to invoke by candlelight. Yet all three fail the same way: thin evidence, romantic appeal, selective citation. We would love for them to be true. None of them earns its keep. The same logic allows our plant medicine to stay.

Now restraint is not silence. Nāhua is defined as much by what we will assert as by what we won't. Our Signal Loss Model proposes that treatment-resistance involves signal loss across three systems: Untethered Cognition, Neuroimmune Dysregulation, and Pursuit-Reward Decoupling. Directed Neuro Dynamics is the practice architecture we build downstream of that model. None of it becomes true because Costa Rica is beautiful, because psychedelics are ancient, or because retreat culture rewards evocative language. Our claims stand or fall on mechanistic coherence, therapeutic fit, and whether the practices we actually run serve the model they claim to serve. Same spotlight, still turned inward.

Setting matters

None of this shrinks the setting. You've heard of "set and setting?" Costa Rica matters. The rainforest matters. Privacy, climate, distance from ordinary life, sensory contrast, the architecture, the sheer ecological volume of the place, all of it matters to the work we do here. "Matters" and "proves" are simply different verbs. A setting can hold and support therapeutic work without being conscripted to prove a scientific claim it was never built to carry. The rainforest is not a mechanism. It is a condition, and it happens to be a breathtaking one.

The stories we refuse to use are part of the model, not an omission from it. In a wellness market thick with borrowed authority, ancestral set dressing, neuroscience theater, and inherited myth, restraint can read at first like a failure of imagination. It is closer to an operating system. Nāhua does not need Costa Rica to be a longevity miracle. It needs the work to be honest, the practices chosen with care, and us to deliver at least as much as we promise.

So, no. It is not a Blue Zone thing. It is closer to the opposite: the daily practice of telling apart what is beautiful, what is plausible, and what has earned the right to guide what we do.

References

Buettner, Dan. 2008. The Blue Zones: Lessons for Living Longer from the People Who Have Lived the Longest. Washington, DC: National Geographic.

Khullar, Dhruv. 2026. “Something Is Very Wrong with Modern Longevity Science.” The New Yorker, June 29.

Newman, Saul Justin. 2026. Morbid: Debunking Modern Longevity Science. Cambridge, MA: MIT Press.

Newman, Saul Justin. 2019. “Supercentenarian and Remarkable Age Records Exhibit Patterns Indicative of Clerical Errors and Pension Fraud.” bioRxiv, revised March 14, 2024.

Rosero-Bixby, Luis. 2008. “The Exceptionally High Life Expectancy of Costa Rican Nonagenarians.” Demography 45 (3): 673–91.

Rosero-Bixby, Luis. 2023. "The Vanishing Advantage of Longevity in Nicoya, Costa Rica: A Cohort Shift." Demographic Research 49 (27): 723–36.

Essays on treatment resistance, altered states, and the conditions under which change becomes possible.

Subscribe